These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32769202)

  • 1. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients.
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32769202
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients.
    van der Zwan M; Hesselink DA; Brusse E; van Doorn PA; van den Hoogen MWF; de Weerd AE; Jacobs BC
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32299841
    [No Abstract]   [Full Text] [Related]  

  • 3. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
    Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
    Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guillain-Barré syndrome associated with cytomegalovirus infection after kidney transplantation].
    Lloveras JJ; Larrue V; Delisle MB; Tack I; Icart J; Dupré C; Ton That H; Durand D; Suc JM
    Presse Med; 1994 Jun; 23(21):976-8. PubMed ID: 7937644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical Clinical Presentations of Pediatric Acute Immune-Mediated Polyneuropathy.
    Yosha-Orpaz N; Aharoni S; Rabie M; Nevo Y
    J Child Neurol; 2019 Apr; 34(5):268-276. PubMed ID: 30674221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
    Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
    Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
    Blum S; McCombe PA
    J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
    van der Meché FG; van Doorn PA
    Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IV Immunoglobulin in Indian Children With Guillain-Barré Syndrome.
    Kalita J; Kumar M; Misra UK
    Pediatr Crit Care Med; 2019 Jul; 20(7):652-659. PubMed ID: 30985608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Ben-Smith A; Gaston JS; Barber PC; Winer JB
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):362-8. PubMed ID: 8890774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Pham HP; Schwartz J
    Presse Med; 2019 Nov; 48(11 Pt 2):338-346. PubMed ID: 31679897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
    Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of factors associated with the development of Guillain-Barré syndrome 2007-2017: what has changed?
    Wachira VK; Peixoto HM; de Oliveira MRF
    Trop Med Int Health; 2019 Feb; 24(2):132-142. PubMed ID: 30444562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demyelinating inflammatory neuropathies, including Guillain-Barré syndrome.
    Steck AJ; Schaeren-Wiemers N; Hartung HP
    Curr Opin Neurol; 1998 Aug; 11(4):311-8. PubMed ID: 9725076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
    Pascual-Pascual SI
    Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis.
    Blum S; Csurhes P; McCombe P
    J Neuroimmunol; 2015 Aug; 285():53-6. PubMed ID: 26198918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy: a case report and review of the literature.
    Olbricht CJ; Stark E; Helmchen U; Schulze M; Brunkhorst R; Koch KM
    Nephron; 1993; 64(1):139-41. PubMed ID: 8502319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.
    Franssen H; Straver DC
    Muscle Nerve; 2014 Jan; 49(1):4-20. PubMed ID: 24037667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2 specific lymphocyte transformation in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
    Taylor WA; Brostoff SW; Hughes RA
    J Neurol Sci; 1991 Jul; 104(1):52-5. PubMed ID: 1717662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.